Trial
NCT06416436
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Solid Tumor
Intervention
Atezolizumab
Why stopped
Impasse during contract negotitations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-29